Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 7

1.

HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes.

Bohlius J, Schmidlin K, Boué F, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Paparizos V, Miro JM, Obel N, Prins M, Chêne G, Egger M; Collaboration of Observational HIV Epidemiological Research Europe.

Blood. 2011 Jun 9;117(23):6100-8. doi: 10.1182/blood-2010-08-301531. Epub 2011 Mar 2.

2.

Can antiretroviral therapy prevent HIV-associated cognitive disorders?

Winston A, Vera JH.

Curr Opin HIV AIDS. 2014 Jan;9(1):11-6. doi: 10.1097/COH.0000000000000016. Review.

PMID:
24275675
3.

Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk.

Borges AH, Dubrow R, Silverberg MJ.

Curr Opin HIV AIDS. 2014 Jan;9(1):34-40. doi: 10.1097/COH.0000000000000025. Review.

4.

Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infection.

Goedert JJ, Bower M.

Curr Opin Oncol. 2012 Sep;24(5):531-6. doi: 10.1097/CCO.0b013e3283560697. Review.

5.

HIV-associated lymphoma in the era of combination antiretroviral therapy: shifting the immunological landscape.

Carroll V, Garzino-Demo A.

Pathog Dis. 2015 Oct;73(7). pii: ftv044. doi: 10.1093/femspd/ftv044. Epub 2015 Jun 29. Review.

PMID:
26121984
6.

Single-pill combination regimens for treatment of HIV-1 infection.

Gandhi M, Gandhi RT.

N Engl J Med. 2014 Jul 17;371(3):248-59. doi: 10.1056/NEJMct1215532. Review. No abstract available.

PMID:
25014689
7.

[When to start antiretroviral therapy].

Elzi L, Battegay M.

Ther Umsch. 2014 Jan;71(1):23-9. doi: 10.1024/0040-5930/a000478. Review. German.

PMID:
24394206
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk